Welcome to the 8 th LURN retreat, March 10 11, Ystad Saltsjöbad, Ystad

Transcription

1 Welcome to the 8 th LURN retreat, March 10 11, 2011 Ystad Saltsjöbad, Ystad

2 Organizing Committee: Gunilla Westergren Thorsson, Jonas Erjefält, Leif Bjermer, Oskar Hallgren, Kristina Rydell Törmänen, Anna Karin Larsson, Marianne Persson and Agneta Hult. Programme coordinators: Anna Karin Larsson, Kristina Rydell Törmänen and Oskar Hallgren Supported by: Astra Zeneca and The Sandberg foundation The Sandberg foundation is represented by; Per Sandberg Evy Sandberg Lennart Linder Aronson Daniel Danielsson Håkan Westling Britt Westling 1

3 March 10 th Thursday Lunch Introduction to LURN 2011 Professor Gunilla Westergen Thorsson, PhD Honorary Sandberg Lecturate Introduction by Professor Claes Göran Löfdahl, MD, PhD Professor Dirkje Postma, MD, PhD, University of Groningen, Groningen, the Netherlands Translational medicine in Groningen about genes, mice and disease Discussion Session A Asthma, allergy and inflammation Chairmen: Professor Vibeke Backer MD, PhD and Cecilia Andersson, PhD Professor Leif Bjermer, MD, PhD Lund University, Lund, Sweden New views on asthma an introduction Hans Grönlund, PhD, Karolinska Institutet, Stockholm, Sweden Allergy to pets; pitfalls and possibilities Discussion Coffee Jenny Calvén, Lund University, Lund, Sweden Airway smooth muscle cells as regulators of innate immune responses in asthma Discussion Maria Lundström, Lund University, Lund, Sweden Alveolar remodeling in relation to nitric oxide in uncontrolled asthma Discussion Anders Bergqvist, Lund University, Lund, Sweden Alveolar Th2 inflammation in uncontrolled asthma Discussion 2

4 Session B Pulmonary immune responses and immune remodeling Chairmen: Elisabet Wieslander, PhD and Ann Rosendahl, PhD Chris Ward, PhD, Newcastle University, Newcastle upon Thyne, UK May cells other than Th17 lymphocytes be important sources of IL 17 in the lung? Discussion Maxie Kohler, PhD, Karolinska Institutet, Stockholm, Sweden Proteomics of bronchoalveolar lavage cells in chronic obstructive pulmonary disease Discussion Michiko Mori, Lund University, Lund, Sweden Immune remodeling in COPD Discussion Abraham Roos, Karolinska Institutet, Stockholm, Sweden C/EBP transcription factors in models of inflammatory lung diseases Discussion Kristina Forsman Semb, PhD, Astra Zeneca R&D, Lund, Sweden Urinary desmosine in relation to lung function, a study from the Swedish twin register Discussion Recreational activities Dinner 3

5 March 11 th Friday Session C Acute lung injury Chairmen: Chris Ward, PhD and Anna Karin Larsson, PhD 8.15 Professor Roland Andersson, MD, PhD, Lund University, Lund, Sweden Acute lung injury in acute pancreatitis what s beyond the horizon? 8.35 Discussion 8.45 Hamid Akbarshahi, MD, Lund University, Lund, Sweden Mediators involved in the acute lung injury induced by acute pancreatitis 8.55 Discussion 9.00 Professor Stefan Uhlig, PhD, RWTH Aachen University, Aachen, Germany The role of sphingolipids in acute lung injury 9.20 Discussion 9.30 Helena Linge, PhD, Feinstein Institute for Medical Research, Manhasset, NY Age dependent changes in the immune response and physiology in experimental pneumonia Discussion Coffee Session D Chronic severe lung diseases and transplantation Chairmen: Professor Jonas Erjefält, PhD and Ellen Tufvesson, PhD Martin Iversen, MD, PhD, Copenhagen University Hospital, Copenhagen, Denmark Immunological mechanisms in chronic rejection in lung transplantation Discussion Annika Andersson Sjöland, PhD, Lund University, Lund, Sweden Mesenchymal stem cells and progenitors in the tissue niche in lung repair Discussion 4

6 11.10 Louise Lannefors, PhD, Lund University, Lund, Sweden Cystic fibrosis long term results of a treatment package including preventive physical exercise Discussion Agneta Scheja, MD, PhD, Lund University, Lund, Sweden Systemic Sclerosis in a 25 year perspective and a glimpse into the future Discussion Session E Sandberg Prize Award and Young Investigator Prize Sandberg Prize Award Introduced by Professor Gunilla Westergren Thorsson Sandberg Prize Lecture Discussion Young Investigator Prize Presented by Professor Gunilla Westergren Thorsson Concluding remarks Professor Leif Bjermer Lunch and departure 5

7 Participants LURN mars 2011 Kristian Aasbjerg Bispebjerg Hospital Copenhagen Mikael Adner Karolinska Institutet Stockholm Hamid Akbarshahi Lund University Lund Lisa Alenmyr Lund University Lund Annika Andersson Sjöland Lund University Lund Cecilia Andersson Lund University Lund Pia Andersson Lund University/SUS Lund Roland Andersson Lund University/SUS Lund Anna Appelberg Lund University Lund Vibeke Backer Bispebjerg Hospital Copenhagen Mariam Bagher Lund University Lund Kinga Balogh AstraZeneca Lund Anders Bergqvist Lund University Lund Leif Bjermer Lund University/SUS Lund Angelica Brandelius Lund University Lund Charlott Brunmark AstraZeneca Lund Eile Butler Lund University Lund Jenny Calvén Lund University Lund Caroline Düringer AstraZeneca Lund Arne Egesten Lund University Lund Anders Eklund Karolinska Institutet Stockholm Gunilla Ekström AnaMar AB Lund Jonas Erjefält Lund University Lund Kristina Forsman Semb AstraZeneca Lund Pernilla Glader Gothenburg University Gothenburg Johan Grunewald Karolinska Institutet Stockholm Hans Grönlund Karolinska Institutet Stockholm Eylem Gürcan AstraZeneca Lund Åsa Gustafsson Totalförsvarets forskningsinst Umeå Lena Gustavsson AstraZeneca Lund Oskar Hallgren Lund University Lund Helene Hansson AstraZeneca Lund Agneta Hult Lund University Lund Martin Iversen Copenhagen Univ Hospital Copenhagen Karin Jansner Lund University Lund Sofia Jonasson Totalförsvarets forskningsinst Umeå Ola Kilsgård Lund University Lund Anna Klepczynska Nyström Karolinska Institutet Stockholm Maxie Kohler Karolinska Institutet Stockholm Solande Korn AstraZeneca Lund Louise Lannefors Lund University/SUS Lund Anna Karin Larsson Lund University Lund Bettina Levänen Karolinska Institutet Stockholm Åsa Lindén AstraZeneca Lund Helena Linge Lund University/USA Lund Kristina Lundberg Immunteknologi, LTH Lund Claes Göran Löfdahl Lund University/SUS Lund 6

8 Irma Mahmutovic Persson Lund University Lund Anders Malmström Lund University Lund Anna Miller Larsson AstraZeneca Lund Michiko Mori Lund University Lund Matthias Mörgelin Lund University Lund Kristian Nihlberg Lund University Lund Ulf Nihlén AstraZeneca Lund Britt Marie Nilsson Lund University Lund Åke Nilsson Lund University/SUS Lund Maria Nordberg AstraZeneca Lund Carl Persson Lund University Lund Celeste Porsbjerg Bispebjerg Hospital Copenhagen Dirkje Postma Groningen University Groningen, NL Lisa Påhlman Lund University Lund Inger Remse AstraZeneca Lund Sara Rolandsson Lund University Lund Abraham Roos Karolinska Institutet Stockholm Ann Rosendahl Lund University Lund Kristina Rydell Törmänen Lund University Lund Frida Rydnert Immunteknologi, LTH Lund Agneta Scheja Lund University/SUS Lund Swati Shukla Lund University Lund Max Siller AnaMar AB Lund Linnea Svensson Lund University Lund Sara Svensson Lund University Lund Asger Sverrild Bispebjerg Hospital Copenhagen Bengt Särnstrand AstraZeneca Lund Wendy Taylor AstraZeneca Lund Lena Thiman Lund University Lund Lina Thors Totalförsvarets forskningsinst Umeå Lars Thorsson AstraZeneca Lund Göran Tornling AstraZeneca Lund Ellen Tufvesson Lund University Lund Alf Tunsäter Lund University/SUS Lund Emil Tykesson Lund University Lund Stefan Uhlig Aachen University Aachen, DE Lena Uller Lund University Lund Chris Ward Newcastle University Newcastle,UK Maria Weitoft Lundström Lund University Lund Christina Wenglén AnaMar AB Lund Gunilla Westergren Thorsson Lund University Lund Elisabet Wieslander AstraZeneca Lund Marie Wildt Lund University/SUS Lund Karin Von Wachenfeldt AstraZeneca Lund Dirk Wuttge Lund University/SUS Lund Julie Yudina Lund University Lund Cang Bao Xu Lund University Lund Yaping Zhang Lund University Lund 7